153 related articles for article (PubMed ID: 38377527)
1. Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting.
Tonti E; Lee YM; Gruenke N; Ferren J; Stutzman DL
J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):52-60. PubMed ID: 38377527
[No Abstract] [Full Text] [Related]
2. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL
Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics: an Update for Child and Adolescent Psychiatry.
Namerow LB; Walker SA; Loftus M; Bishop JR; Ruaño G; Malik S
Curr Psychiatry Rep; 2020 May; 22(5):26. PubMed ID: 32377970
[TBL] [Abstract][Full Text] [Related]
4. Drug Prescribing and Outcomes After Pharmacogenomic Testing in a Developmental and Behavioral Health Pediatric Clinic.
Patel JN; Mueller MK; Guffey WJ; Stegman J
J Dev Behav Pediatr; 2020 Jan; 41(1):65-70. PubMed ID: 31688658
[TBL] [Abstract][Full Text] [Related]
5. A Narrative Review on Pharmacogenomics in Psychiatry: Scientific Definitions, Principles, and Practical Resources.
Palumbo S; Mariotti V; Pellegrini S
J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):49-56. PubMed ID: 38100778
[TBL] [Abstract][Full Text] [Related]
6. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
[TBL] [Abstract][Full Text] [Related]
7. Review and Consensus on Pharmacogenomic Testing in Psychiatry.
Bousman CA; Bengesser SA; Aitchison KJ; Amare AT; Aschauer H; Baune BT; Asl BB; Bishop JR; Burmeister M; Chaumette B; Chen LS; Cordner ZA; Deckert J; Degenhardt F; DeLisi LE; Folkersen L; Kennedy JL; Klein TE; McClay JL; McMahon FJ; Musil R; Saccone NL; Sangkuhl K; Stowe RM; Tan EC; Tiwari AK; Zai CC; Zai G; Zhang J; Gaedigk A; Müller DJ
Pharmacopsychiatry; 2021 Jan; 54(1):5-17. PubMed ID: 33147643
[TBL] [Abstract][Full Text] [Related]
8. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
[TBL] [Abstract][Full Text] [Related]
9. Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting.
Brown LC; Lorenz RA; Li J; Dechairo BM
Clin Ther; 2017 Mar; 39(3):592-602.e1. PubMed ID: 28238356
[TBL] [Abstract][Full Text] [Related]
10. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
[TBL] [Abstract][Full Text] [Related]
11. Assessing Clinical Utility of Pharmacogenetic Testing in the Military Health System.
Hellwig LD; Turner C; Olsen C; Libbus J; Markos B; Koehlmoos T; Haigney M; De Castro M; Saunders D
Mil Med; 2024 Jan; 189(1-2):e198-e204. PubMed ID: 37436924
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review.
Yoshida K; Koyama E; Zai CC; Beitchman JH; Kennedy JL; Lunsky Y; Desarkar P; Müller DJ
Can J Psychiatry; 2021 Dec; 66(12):1019-1041. PubMed ID: 33222504
[TBL] [Abstract][Full Text] [Related]
13. Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study.
Jameson A; Faisal M; Fylan B; Bristow GC; Sohal J; Dalton C; Sagoo GS; Cardno AG; McLean SL
J Psychopharmacol; 2024 Apr; 38(4):382-394. PubMed ID: 38494658
[TBL] [Abstract][Full Text] [Related]
14. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Del Toro-Pagán NM; Matos A; Thacker D; Turgeon J; Amin NS; Michaud V
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577878
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics in psychiatry - the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosing.
Mostafa S; Polasek TM; Bousman CA; Müeller DJ; Sheffield LJ; Rembach J; Kirkpatrick CM
Pharmacogenomics; 2022 Oct; 23(15):857-867. PubMed ID: 36169629
[TBL] [Abstract][Full Text] [Related]
17. Variations in Mental Health Diagnosis and Prescribing Across Pediatric Primary Care Practices.
Mayne SL; Ross ME; Song L; McCarn B; Steffes J; Liu W; Margolis B; Azuine R; Gotlieb E; Grundmeier RW; Leslie LK; Localio R; Wasserman R; Fiks AG
Pediatrics; 2016 May; 137(5):. PubMed ID: 27244791
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated with Developmental Behavioral Pediatricians Prescribing Psychotropic Medication to Children with Autism Spectrum Disorder: A Study of Three DBPNet Sites.
Jackel C; Shults J; Wiley S; Meinzen-Derr J; Augustyn M; Blum N
J Dev Behav Pediatr; 2017 Oct; 38(8):584-592. PubMed ID: 28816917
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
[TBL] [Abstract][Full Text] [Related]
20. Effect of pharmacogenomic testing on pharmacotherapy decision making in patients with symptoms of depression in an interprofessional primary care clinic.
Roscizewski L; Henneman A; Snyder T
J Am Pharm Assoc (2003); 2022; 62(2):569-574.e1. PubMed ID: 34801407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]